Table of Contents
Analyzing the Hepatitis C Market Landscape After more than a decade of limited treatment options, the hepatitis C (HCV) market is on the cusp of a treatment revolution. In 2011, protease inhibitors-Incivek (telaprevir; Vertex) and Victrelis (boceprevir; Merck)-became the first new drugs approved in the disease in over a decade; however after a bright start sales have ...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Alison
00 1 718 618 48 97
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...
Actonel (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Actonel (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
REPORT SCOPE INTRODUCTION REASONS FOR DOING THE STUDY The spread of human immunodeficiency virus (HIV), hepatitis B and C, evolving influenza strains and antibiotic-resistant organisms have put healthcare ...
... Reduce respiratory depression Long-acting profile Properties inherent to molecule source: ims midas; resources global chronic pain therapy market received fast track status from fda ...
... Associated urinary tract infection (cauti) outcome measure (nqf #0138) rti international measures application partnership (map) The measure applications partnership is a public- private partnership ...
Company Profiles10 Companies
Reportlinker.com © Copyright 2013. All rights reserved.